We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




First Real-Time Adaptive Radiation Therapy in 10 Minutes or Less

By HospiMedica International staff writers
Posted on 19 Aug 2009
New treatment planning technology is one of the first real-time adaptive radiation therapy systems, resulting in high quality plans that can be produced in approximately 10 minutes or less and does not require patient repositioning or extensive replanning processes.

With current image-guided systems, clinicians have the ability to track shape changes in a patient's anatomy between treatments, but unfortunately, this does not allow for adjustments in the treatment plan prior to the treatment delivery within an acceptable timeframe. More...
The IM-RealART system accounts for the difference in the patient from scan to scan, while still maintaining the same timeslots.

Siemens Healthcare (Erlangen, Germany) presented the IM-RealAR system at the 51st annual meeting of the American Association of Physicists in Medicine (AAPM) in Anaheim, CA, USA, July 26-30, 2009. "Image-plan-treatment is the wave of the future in radiation therapy,” said X. Allen Li, Ph.D., DABMP, FAAPM, chief of physics and professor at the Medical College of Wisconsin (Milwaukee, USA). "With IM-RealART, I can create new plans in as little as eight minutes, enabling me to make real-time corrections to the plan based on the interfractional anatomy variations.”

The IM-RealART system is designed specifically for immediate replanning within image-guided radiation therapy (IGRT). It combines Siemens CTVision system with the Prowess RealART treatment planning system, offering diagnostic-quality, in-room imaging, while allowing physicians to react immediately to changes in patient anatomy and replan the treatment on the spot.

"With the speed and accuracy of IM-RealART solution, plans can be quickly adapted and delivered, with the further advantage of targeting only the regions that need to be treated, sparing healthy tissue,” said Wolfgang Rueger, vice president, oncology care systems, Siemens Healthcare. "Precise targeting and accurate plans allow for optimal patient care.”

Related Links:

Siemens Healthcare



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Medical Monitor
VITALMAX 4100SL
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.